ABSTRACT
The incidence of dengue virus disease has increased globally across the past half-century, with highest number of cases ever reported in 2019. We analyzed climatological, epidemiological, and phylogenomic data to investigate drivers of two decades of dengue virus disease in Cambodia, an understudied endemic setting. Using epidemiological models fit to a 19-year dataset, we first demonstrate that climate-driven transmission alone is insufficient to explain three epidemics across the time series. We then use wavelet decomposition to highlight enhanced annual and multiannual synchronicity in dengue cycles between provinces in epidemic years, suggesting a role for climate in homogenizing dynamics across space and time. Assuming reported cases correspond to symptomatic secondary infections, we next use an age-structured catalytic model to capture a trend of declining force of dengue infection through time, which drives observed patterns of increasing mean age of reported cases in Cambodia. Reported cases in >70 year-old individuals in epidemic years are best explained when additionally allowing for waning multitypic immunity and repeat symptomatic infections in older cohorts. We support this work with time-resolved phylogenetic trees incorporating 122 dengue virus (DENV) genomes sequenced in the 2019-2020 epidemic, which document introduction of DENV-2 Cosmopolitan genotype into Cambodia, yielding localized transmission and decreased genomic diversity compared to endemic DENV-1. Finally, we simulate an age-structured, mechanistic model of dengue dynamics to demonstrate how introduction of a genetically distinct lineage into a population with waning multitypic immunity could drive repeat infections within a serotype in older-age individuals and recover patterns from reported data.
CLINICAL TRIAL NUMBERS NCT04034264 and NCT03534245.
SIGNIFICANCE STATEMENT The year 2019 witnessed the highest number of dengue cases ever reported, including in Cambodia, a Southeast Asian country with endemic transmission. We analyzed two decades of national dengue surveillance data for Cambodia to demonstrate how increasing temperature and precipitation enhance spatiotemporal synchronicity in epidemic years. We document how twenty years of demographic transition has increased the age of reported dengue infection and correspondingly depressed the force of infection through time. We show that introduction of a divergent DENV-2 genotype in Cambodia in 2019 likely drove repeated symptomatic infections in older-age individuals that contributed to a high burden epidemic. As climates warm, we are likely to see more synchronized dynamics globally and a shifting burden of symptomatic disease into older cohorts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and the Bill and Melinda Gates Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Ethics Committee for Human Research of the Cambodian Ministry of Health gave ethical approval for this work. The Institutional Review Board of the US National Institutes of Health gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We have updated the author listed, edited the Discussion, edited the author contributions, and added Tables to the Supplementary Information Appendix.
Data Availability
All genome sequence data from this study have been submitted to the NCBI Sequence Read Archive under Bioproject ID PRJNA681566. Consensus DENV sequences are also available in GenBank, under the following accession numbers: DENV-1: OK159935-OK159976, OL411495-OL411499, and OL412140, OL412678, and OL412703; DENV-2: OL414717-OL414765, OL412740, OL420733 and OL435143; DENV-4: MZ976858-MZ976860).
https://github.com/chanzuckerberg/idseq-workflows
https://artic.readthedocs.io/en/latest/
https://docs.google.com/document/d/1RtNQc1D4or_ys7OxCCBjh4SDIdy7JaI4IE7if8EkHgE/edit
